stock

Zoetis, Inc. (ZTS)

0
September 3rd, 2020

Share

Stay up to date

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Financial Statements

Key Info

  • Industry: Pharmaceuticals: Generic
  • Sector: Health Technology
  • CEO Name: Kristin C. Peck

Key Statistics

  • Stock Price: $165.33
  • Dividend Yield: 0.5%
  • Market Capitalization: $78,555,722,850
  • Shares Outstanding: 475,145,000
  • Number of Employees: 10,600
  • Trailing 12-Month EPS: $3.39
  • Trailing 12-Month DPS: $0.76
  • Payout Ratio: 22.400000000000002%

Important Dates

  • Next Earnings Date: 2020-10-21
  • Next Ex-Dividend Date: 2020-07-16

Price Trends

  • Current Stock Price: $165.33
  • 52-week high: $165.82
  • 52-week low: $90.14
  • 200-day moving average: $134.61
  • 50-day moving average: $149.31

Performance

  • 1-Month Price Return: 7.0%
  • 3-Month Price Return: 16.0%
  • 6-Month Price Return: 20.5%
  • 1-Year Price Return: 30.1%
  • 2-Year Price Return: 58.6%
  • 5-Year Price Return: 166.1%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020